FIELD: chemistry.
SUBSTANCE: present invention discloses a method of purifying liraglutide by reverse-phase high-performance liquid chromatography using selective agents for forming an ion pair, which enables to purify crude liraglutide from closely related impurities.
EFFECT: purification of glucagon-like peptide-1 analogues is disclosed.
6 cl, 4 dwg, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
CHROMATOGRAPHIC METHODS AND COMPOUNDS PURIFIED USING SAID METHODS | 2010 |
|
RU2508294C2 |
METHOD OF PURIFYING CYCLIC OR ACYCLIC PEPTIDE | 2008 |
|
RU2461564C2 |
PREPARATIVE CHROMATOGRAPHIC METHOD BASED ON NON-LINEAR GRADIENT AND PRODUCTS CLEANED WITH THIS METHOD | 2010 |
|
RU2489441C1 |
METHOD FOR PRODUCING CALCOBUTROL | 2019 |
|
RU2779668C1 |
OPTIMIZED METHOD FOR PRODUCTION OF DIMERIC PEPTIDE-PHOSPHOLIPID CONJUGATE | 2019 |
|
RU2784866C1 |
METHOD TO PRODUCE RECOMBINANT INSULIN GLARGINE | 2008 |
|
RU2495131C2 |
LIRAGLUTIDE SYNTHESIS | 2017 |
|
RU2766331C2 |
METHOD FOR QUANTITATIVELY DETERMINING INDIVIDUAL STREPTOTRICINES | 2006 |
|
RU2322673C2 |
METHOD FOR PREPARING HIGH-PURITY CRYSTALLINE INSULIN OF ANY ORIGIN | 2011 |
|
RU2453331C1 |
HUMAN RECOMBINANT INTERLEUKIN-2 | 1992 |
|
RU2105011C1 |
Authors
Dates
2024-04-02—Published
2020-02-05—Filed